Alvotech (ALVO) Interest & Investment Income (2021 - 2026)

Alvotech (ALVO) posted Interest & Investment Income of $33.4 million for Q1 2026, up 20.17% on a QoQ basis from $27.8 million in Q4 2025, and down 73.55% year-over-year from $126.3 million in Q1 2025.

Alvotech (ALVO) Interest & Investment Income (2021 - 2026) Analysis & Trends

Alvotech's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $33.4 million for Q1 2026.

  • Quarterly Interest & Investment Income fell 73.55% year-over-year to $33.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.6 million (down 48.85% YoY) and the FY2025 annual result came in at $198.5 million, up 147.67% from the prior year.
  • Interest & Investment Income was $33.4 million for Q1 2026 at Alvotech, up from $27.8 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $126.3 million in Q1 2025 and bottomed at -$41.6 million in Q4 2023.
  • A 5-year average of $39.3 million and a median of $27.8 million in 2025 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2023 — Interest & Investment Income slumped 181.54% — and 2025, when it soared 16131189.91%.
  • Alvotech's Interest & Investment Income stood at $51.0 million in 2022, then slumped by 181.54% to -$41.6 million in 2023, then surged by 102.56% to $1.1 million in 2024, then surged by 2508.35% to $27.8 million in 2025, then rose by 20.17% to $33.4 million in 2026.
  • Business Quant data shows ALVO's Interest & Investment Income at $33.4 million in Q1 2026, $27.8 million in Q4 2025, and $21.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Alvotech 907.91 Mn 907.91 Mn 5.09 Mn 33.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.41 Mn
Dec 31, 2025 27.81 Mn
Sep 30, 2025 21.44 Mn
Jun 30, 2025 22.94 Mn
Mar 31, 2025 126.31 Mn
Dec 31, 2024 1.07 Mn
Sep 30, 2024 -1.74 Mn
Jun 30, 2024 80.82 Mn
Mar 31, 2024 783.00
Dec 31, 2023 -41.56 Mn
Aug 31, 2023 122.48 Mn
Jun 30, 2023 122.48 Mn
Mar 31, 2023 1,226.00
Dec 31, 2022 50.97 Mn
Aug 31, 2022 50.97 Mn
Jun 30, 2022 50.96 Mn
Mar 31, 2022 4,000.00
Dec 31, 2021 51.56 Mn
Sep 30, 2021 3,000.00